tim.philippi@bi... 在 星期五, 05/13/2016 - 15:24 提交
Date:
星期二, 五月 10, 2016 - 10:00
Featuring:
Dr. Birte Aggeler, Director of Antibody Development
Description:
This webinar will introduces the different concepts of recombinant antibodies and specifically the approach that Bio-Techne has taken to develop new tools and technologies in combining our extensive experiences in molecular biology and antibody development.
Dr. Birte Aggeler presents data on recombinant rabbit monoclonals, hybridoma conversion antibodies (rat and mouse), and our new line of goat monoclonals. Once an antibody has been cloned the possibilities of modifications and additions are wide open and we present data on Fab’2, Fc mutations to eliminate non-specific binding to monocytes as well as isotype changes and early work with enzyme modifications.